Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
Elizabeth M. Swisher, Kevin K. Lin, Amit M. Oza, Clare L. Scott, Heidi Giordano, James Sun, Gottfried E. Konecny, Robert L. Coleman, Anna V. Tinker, David M. O'Malley, Rebecca S. Kristeleit, Ling Ma, Katherine M. Bell-McGuinn, James D. Brenton, Janiel M. Cragun, Ana Oaknin, Isabelle Ray-Coquard, Maria I. Harrell, Elaina Mann, Scott H. KaufmannAnne Floquet, Alexandra Leary, Thomas C. Harding, Sandra Goble, Lara Maloney, Jeff Isaacson, Andrew R. Allen, Lindsey Rolfe, Roman Yelensky, Mitch Raponi, Iain A. McNeish
Dive into the research topics of 'Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial'. Together they form a unique fingerprint.